VOYA Investment Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.6M Buy
505,034
+174,605
+53% +$17.5M 0.05% 298
2025
Q4
$33.8M Sell
330,429
-25,992
-7% -$2.33M 0.03% 387
2025
Q3
$22.3M Sell
356,421
-193,157
-35% -$10.5M 0.02% 469
2025
Q2
$28.6M Buy
549,578
+76,679
+16% +$3.42M 0.03% 444
2025
Q1
$20.1M Buy
472,899
+309,254
+189% +$13.3M 0.02% 517
2024
Q4
$5M Buy
163,645
+125,238
+326% +$3.52M 0.01% 971
2024
Q3
$881K Sell
38,407
-1,844
-5% -$52.2K ﹤0.01% 1714
2024
Q2
$1.16M Buy
40,251
+2,215
+6% +$51.6K ﹤0.01% 1552
2024
Q1
$785K Sell
38,036
-7,126
-16% -$153K ﹤0.01% 1764
2023
Q4
$1.22M Sell
45,162
-13,009
-22% -$341K ﹤0.01% 1582
2023
Q3
$1.72M Buy
58,171
+14,162
+32% +$498K ﹤0.01% 1388
2023
Q2
$1.58M Buy
44,009
+4,608
+12% +$132K ﹤0.01% 1447
2023
Q1
$924K Sell
39,401
-1,331,849
-97% -$38M ﹤0.01% 1699
2022
Q4
$37.3M Buy
1,371,250
+57,207
+4% +$2.62M 0.04% 397
2022
Q3
$70.7M Buy
1,314,043
+1,272,714
+3,079% +$65.3M 0.08% 263
2022
Q2
$1.67M Sell
41,329
-2,272
-5% -$113K ﹤0.01% 1177
2022
Q1
$2.89M Sell
43,601
-863
-2% -$59.1K 0.01% 1001
2021
Q4
$4.45M Buy
44,464
+16,087
+57% +$1.66M 0.01% 887
2021
Q3
$3.55M Sell
28,377
-583
-2% -$69.3K 0.01% 954
2021
Q2
$3.6M Buy
28,960
+1,764
+6% +$237K 0.01% 976
2021
Q1
$4.15M Sell
27,196
-1,774
-6% -$268K 0.01% 908
2020
Q4
$3.73M Buy
28,970
+1,201
+4% +$138K 0.01% 909
2020
Q3
$3.1M Sell
27,769
-888
-3% -$81.2K 0.01% 885
2020
Q2
$2.33M Buy
28,657
+15,452
+117% +$1.24M 0.01% 968
2020
Q1
$919K Sell
13,205
-312
-2% -$23.9K ﹤0.01% 1269
2019
Q4
$1.06M Buy
13,517
+3,464
+34% +$250K ﹤0.01% 1424
2019
Q3
$642K Buy
10,053
+564
+6% +$49.7K ﹤0.01% 1597
2019
Q2
$819K Buy
9,489
+3,730
+65% +$285K ﹤0.01% 1466
2019
Q1
$442K Hold
5,759
﹤0.01% 1846
2018
Q4
$216K Buy
+5,759
New +$212K ﹤0.01% 2191

Other funds holding GH

VOYA Investment Management's GH Position: Q1 2026 in Review

VOYA Investment Management increased its Guardant Health (GH) stake by 53% in Q1 2026, buying an estimated $17.5M and bringing the position to 505,034 shares worth $46.6M. The position accounts for 0.05% of the portfolio, ranked #298.

VOYA Investment Management first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $70.7M in Q3 2022. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • VOYA Investment Management held 505,034 shares of Guardant Health worth $46.6M as of Q1 2026.
  • VOYA Investment Management bought 174,605 Guardant Health shares in Q1 2026, an estimated $17.5M.
  • Guardant Health made up 0.05% of VOYA Investment Management's portfolio in Q1 2026, its #298 holding.
  • VOYA Investment Management first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • VOYA Investment Management's Guardant Health position peaked at $70.7M in Q3 2022.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.